Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

被引:0
|
作者
Charles Oo
George Hill
Albert Dorr
Baolian Liu
Samuel Boellner
Penelope Ward
机构
[1] Roche Global Development,
[2] Aventis Pharmaceutical Inc. 1041,undefined
[3] Roche Global Development,undefined
[4] XIQ Coordination Inc.,undefined
[5] Clinical Study Center,undefined
[6] Roche Global Development,undefined
来源
European Journal of Clinical Pharmacology | 2003年 / 59卷
关键词
Oseltamivir; Children;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:411 / 415
页数:4
相关论文
共 50 条
  • [41] Early Use of Anti-influenza Medications in Hospitalized Children With Tracheostomy
    Miyakawa, Ryo
    Barreto, Nicolas B.
    Kato, Roberta M.
    Neely, Michael N.
    Russell, Christopher J.
    PEDIATRICS, 2019, 143 (03)
  • [42] The synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu®):: A challenge for synthesis & process research
    Abrecht, S
    Harrington, P
    Iding, H
    Karpf, M
    Trussardi, R
    Wirz, B
    Zutter, U
    CHIMIA, 2004, 58 (09) : 621 - 629
  • [43] Antiarrhythmic effect of the anti-influenza drug oseltamivir in an experimental whole-heart model of atrial fibrillation
    Ellermann, C.
    Mittelstedt, A.
    Eckardt, L.
    Frommeyer, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 576 - 576
  • [44] PREVENTIVE ANTI-INFLUENZA EFFECT OF EXOGENOUS LEUKOCYTE INTERFERON IN CHILDREN
    MAKAROVA, ZS
    TONKOVAYAMPOLSKAYA, RV
    NEKLYUDOVA, LI
    CHERTOK, TY
    FEDOROVA, YB
    GUMENNIK, AE
    KUZNETSOV, VP
    VOPROSY VIRUSOLOGII, 1981, (05) : 565 - 567
  • [45] Electrophysiological Effects of an Anti-influenza Drug Oseltamivir on the Guinea-Pig Atrium: Comparison with Those of Pilsicainide
    Takahara, Akira
    Suzuki, Sanae
    Hagiwara, Mihoko
    Nozaki, Shuhei
    Sugiyama, Atsushi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (10) : 1650 - 1652
  • [46] Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity
    Hong, Bei-Tao
    Cheng, Yih-Shyun E.
    Cheng, Ting-Jen
    Fang, Jim-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 710 - 721
  • [47] A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents
    Jung, Yujeong
    Ahn, Soo Bin
    An, Taeyang
    Cha, Hyeon-Min
    Kim, Minjae
    Cheon, Hyunjin
    Jang, Yejin
    Lee, Haemi
    Kim, Byungil
    Kim, Meehyein
    Lee, Yan
    ACS CENTRAL SCIENCE, 2024, 10 (08) : 1573 - 1584
  • [48] High-Yielding Synthesis of the Anti-Influenza Neuraminidase Inhibitor (-)-Oseltamivir by Two "One-Pot" Sequences
    Ishikawa, Hayato
    Suzuki, Takaki
    Orita, Hideo
    Uchimaru, Tadafumi
    Hayashi, Yujiro
    CHEMISTRY-A EUROPEAN JOURNAL, 2010, 16 (42) : 12616 - 12626
  • [49] High-Yielding Synthesis of the Anti-Influenza Neuramidase Inhibitor (-)-Oseltamivir by Three "One-Pot" Operations
    Ishikawa, Hayato
    Suzuki, Takaki
    Hayashi, Yujiro
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (07) : 1304 - 1307
  • [50] Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age: A Randomized Controlled Trial
    Heinonen, Santtu
    Silvennoinen, Heli
    Lehtinen, Pasi
    Vainionpaa, Raija
    Vahlberg, Tero
    Ziegler, Thedi
    Ikonen, Niina
    Puhakka, Tuomo
    Heikkinen, Terho
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (08) : 887 - 894